FDA Inspection 1267717 — Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health
The FDA completed an inspection of Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health on April 18, 2025 in Sunnyvale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 18, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Sunnyvale, CA (United States)